Nitusca et al. elucidated that NEAT1 exhibits clinical interest in diagnosing PCa where it was markedly high among patients and achieved AUC = 0.72 (Nitusca et al. 2021). This evidence concerns the gene NEAT1 and posterior cortical atrophy.